Press Releases
Keyword Search
03.30.23
CORRECTION – OpGen Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
03.29.23
OpGen Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
03.22.23
OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year 2022 on March 29th at 4:30 p.m. Eastern Time
03.01.23
OpGen Subsidiary Ares Genetics Announces its Move to New Vienna Location and Provides Update on Business Growth
02.17.23
OpGen Announces Exercise of All Prefunded Warrants
01.26.23
OpGen subsidiary Ares Genetics announces granting of key patent in China
01.18.23
OpGen Provides Preliminary Unaudited Revenue for FY 2022 and Business Update
01.17.23
OpGen Subsidiary Curetis Meets Several Key Milestones in FIND Collaboration Project
01.11.23
OpGen Announces Closing of $7.5 Million Public Offering
01.06.23
OpGen Announces Pricing of $7.5 Million Public Offering